Mr. Jean-François Tiné joined the Audit Committee. In May 2024, the Board of Directors appointed Ms. Katherine Kalin as member of the ESG Committee. II. 2H24 and beyond: key milestones and outlook PBC Following the positive CHMP recommendation, the European Commission is expected to take a final decision on marketing authorization for Iqirvo in the second half of 2024.